Showing results (1211-1220 of 3,473) with videos related to
Sort By:
Pageof 348
Clinical Pharmacokinetics|February 1, 1988
Clinical pharmacokinetics of the newer antibacterial 4-quinolonesM NeumanClinical Pharmacokinetics|April 8, 2021
Pharmacokinetics and Drug-Drug Interactions of Long-Acting Intramuscular Cabotegravir and RilpivirineDaryl Hodge, David J Back, Sara Gibbons, et al.Clinical Pharmacokinetics|April 16, 2015
Jejunal Infusion of levodopa-carbidopa intestinal gel versus oral administration of levodopa-carbidopa tablets in japanese subjects with advanced Parkinson's disease: pharmacokinetics and pilot efficacy and safetyAhmed A Othman, Krai Chatamra, Mohamed-Eslam F Mohamed, et al.Clinical Pharmacokinetics|March 29, 2023
Neither Gastric Bypass Surgery Nor Diet-Induced Weight-Loss Affect OATP1B1 Activity as Measured by Rosuvastatin Oral ClearanceMarkus Hovd, Ida Robertsen, Line Kristin Johnson, et al.Clinical Pharmacokinetics|May 14, 2023
Population Pharmacokinetics of Posaconazole in Immune-Compromised Children and Assessment of Target Attainment in Invasive Fungal DiseaseSean McCann, Jaydeep Sinha, William S Wilson, et al.Clinical Pharmacokinetics|July 4, 2001
Concentration-controlled or effect-controlled trials: useful alternatives to conventional dose-controlled trials?A Grahnén, M O KarlssonClinical Pharmacokinetics|July 4, 2001
Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterialsW J Burman, K Gallicano, C PeloquinClinical Pharmacokinetics|July 4, 2001
Application of a gamma model of absorption to oral cyclosporinJ Debord, E Risco, M Harel, et al.Clinical Pharmacokinetics|July 4, 2001
Pharmacokinetic-pharmacodynamic relationship of levodopa with and without tolcapone in patients with Parkinson's diseaseH Baas, F Zehrden, R Selzer, et al.Clinical Pharmacokinetics|September 12, 2002
Virus-based gene delivery systemsCathryn Mah, Barry J Byrne, Terence R FlottePageof 348